The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

SGMT FINANCIAL STATEMENTS

Sagimet Biosciences Inc. Series A Common Stock — balance sheet, income statement and cash flow trends

SGMTSagimet Biosciences Inc. Series A Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-60 M-40 M-20 M02020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Operating Income-52.6 M $ · -Infinity%Pre-tax Income-47.1 M $ · -Infinity%Net Income to Owners-47.1 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit——
Operating Income-52.6 M $—
EBITDA-49.7 M $—
Net Income to Owners-47.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-200 M0200 M2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets263.4 M
  • Equity256.2 M $97%
  • Current Liabilities6.6 M $2%
  • Long-term Liabilities1.9 M $1%

Key Figures

YoY change
Total Assets263.4 M $+91.7%
Total Liabilities8.4 M $+16.0%
Total Equity256.2 M $+96.8%
Cash & ST Investments240.1 M $+91.5%
Total Debt1.9 M $+1,176.3%
Net Debt-164 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-40 M-20 M02020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M300 M-41.3 M $Operating629 K $Investing339.7 M $Financing299 M $Net Change

Key Figures

YoY change
Operating Cash Flow-41.3 M $—
Capital Expenditures0 $—
Free Cash Flow-41.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SGMT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.